Tolstoy’s Great Man

5 December 2017 By Robert Cyran

Mark Bertolini’s payday from selling the insurer to drugstore chain CVS stems largely from steady success and not selling shares amassed over the years. Yet Aetna’s performance is nothing special compared to peers. Genius is easy to find when there’s a heavy wind behind a sector.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)